HR 5239
Endometrial Cancer Research and Education Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Endometrial Cancer Research and Education Act of 2025, aims to increase research and public awareness about endometrial cancer. It directs the National Institutes of Health (NIH) to expand research programs, particularly focusing on disparities in diagnosis and treatment between racial and ethnic groups, and to ensure representation of African-American women in clinical trials. The bill also establishes a public education program through the Centers for Disease Control and Prevention (CDC) to provide information about the disease, its risk factors, and available treatments, with a specific focus on reaching African-American women.
Key provisions
- Directs the NIH to expand research on endometrial cancer.
- Requires the NIH to communicate research findings and disparities to medical professionals and researchers.
- Mandates representation of African-American women in NIH-supported clinical trials.
- Establishes a public education program through the CDC to disseminate information about endometrial cancer.
- The public education materials must target African-American women.
- Authorizes appropriations of $1,000,000 per year for fiscal years 2026-2028 for NIH research.
- Authorizes appropriations for the CDC’s public education program for fiscal years 2026-2028.
- Requires coordination between the NIH and other relevant institutes (NICHD, NIMHD, and ORWH).
Who is affected
- Women
- African-American women
- Asian women
- Researchers
- Medical professionals
Notable changes
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Eleanor Holmes [D-DC-At Large] Norton
Henry C. "Hank" Johnson
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
H. R. 5239
IN THE HOUSE OF REPRESENTATIVES
A BILL
To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.
This Act may be cited as the Endometrial Cancer Research and Education Act of 2025
.
Congress finds the following:
Endometrial cancer is the fourth most common cancer diagnosed in women, after breast, lung, and colon cancer.
Endometrial cancer mainly affects postmenopausal women, with most women diagnosed between age 55 and 64.
Unlike most other types of cancer, the incidence of endometrial cancer, particularly aggressive subtypes of such cancer, has been increasing in the United States among all women, particularly among African-American and Asian women, with a 2.5 annual percent change for both groups.
In comparison to non-Hispanic White women, African-American women have significantly higher incidence rates of aggressive endometrial cancers.
Although non-Hispanic White women are more likely to be diagnosed with endometrial cancer in comparison to African-American women, the rate of mortality is higher for African-American women.
expand, intensify, and coordinate programs to conduct and support research with respect to endometrial cancer;
communicate to medical professionals and researchers, including through the endometrial cancer public education program established under section 399V–8, the disparity in the diagnosis of endometrial cancer between African-American women and non-Hispanic White women and any new research relating to endometrial cancer; and
ensure that African-American women are represented in clinical trials conducted or supported by the National Institutes of Health with respect to endometrial cancer in appropriate proportion to incidence rates of such cancer for African-American women.
the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development;
the Director of the National Institute on Minority Health and Health Disparities; and
the Director of the Office of Research on Women’s Health.
For purposes of carrying out this section, there is authorized to be appropriated $1,000,000 for each of fiscal years 2026 through 2028.
The informational materials under subsection (a) shall include materials targeted toward African-American women.
In developing and disseminating informational materials under subsection (a), the Director of the Centers for Disease Control and Prevention shall consult with the Administrator of the Health Resources and Services Administration.
For purposes of carrying out this section, there is authorized to be appropriated such sums as may be necessary for each of fiscal years 2026 through 2028.